Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1

NCT04396236 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT04396236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04396236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Terminated
Start date
June 15, 2020
Completion date
November 12, 2025
Enrollment
847 (actual)
Sites
152

Conditions

As the registry lists them; a condition with its own page is linked.

migraine